{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:51:33Z","timestamp":1783525893403,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s00393-014-1378-z","type":"journal-article","created":{"date-parts":[[2014,8,5]],"date-time":"2014-08-05T11:40:35Z","timestamp":1407238835000},"page":"532-540","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Biologikatherapie der juvenilen idiopathische Arthritis im jungen Erwachsenenalter","Therapy of juvenile idiopathic arthritis in early adulthood with biologics"],"prefix":"10.1007","volume":"73","author":[{"given":"M.","family":"Niewerth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Minden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Klotsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Horneff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,7]]},"reference":[{"key":"1378_CR1","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1002\/art.30502","volume":"63","author":"Baszis","year":"2011","unstructured":"Baszis K, Garbutt J, Toib D et al (2011) Clinical outcomes after withdrawal of anti-tumor necrosis factor \u03b1 therapy in patients with juvenile idiopathic arthritis: a twelve-year experience. Arthritis Rheum 63(10):3163\u20133168","journal-title":"Arthritis Rheum"},{"key":"1378_CR2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1055\/s-0032-1327599","volume":"120","author":"Bazarra-Castro","year":"2012","unstructured":"Bazarra-Castro M\u00c1, Sievers C, Schwarz HP et al (2012) Changes in BMI and management of patients with childhood onset growth hormone deficiency in the transition phase. Exp Clin Endocrinol Diabetes 120:507\u2013510","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"1378_CR3","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1002\/art.34373","volume":"64","author":"Consolaro","year":"2012","unstructured":"Consolaro A, Bracciolini G, Ruperto N et al (2012) Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: defining criteria based on the juvenile arthritis disease activity score. Arthritis Rheum 64:2366\u20132374","journal-title":"Arthritis Rheum"},{"key":"1378_CR4","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/art.10863","volume":"48","author":"Foster","year":"2003","unstructured":"Foster HE, Marshall N, Myers A et al (2003) Outcome in adults with juvenile idiopathic arthritis: a quality of life study. Arthritis Rheum 48:767\u2013775","journal-title":"Arthritis Rheum"},{"key":"1378_CR5","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJM199204163261602","volume":"326","author":"Giannini","year":"1992","unstructured":"Giannini EH, Brewer EJ, Kuzmina N et al (1992) Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.\u2013U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and the Cooperative Children\u2019s Study Group. N Engl J Med 326:1043\u20131049","journal-title":"N Engl J Med"},{"key":"1378_CR6","first-page":"499","volume":"24","author":"Hanova","year":"2006","unstructured":"Hanova P, Pavelka K, Dostal C et al (2006) Epidemiology of rheumatoid arthritis, juvenile idiopathic arthritis and gout in two regions of the Czech Republic in a descriptive population-based survey in 2002\u20132003. Clin Exp Rheumatol 24(5):499\u2013507","journal-title":"Clin Exp Rheumatol"},{"key":"1378_CR7","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1136\/ard.2003.014886","volume":"63","author":"Horneff","year":"2004","unstructured":"Horneff G, Schmeling H, Biedermann T et al (2004) The German etanercept registry for treatment of juvenile idiopathic arthritis. Ann Rheum Dis 63(12):1638\u20131644","journal-title":"Ann Rheum Dis"},{"key":"1378_CR8","doi-asserted-by":"crossref","unstructured":"Hyrich KL, Lal SD, Foster HE et al (2010) Disease activity and disability in children with juvenile idiopathic arthritis one year following presentation to paediatric rheumatology. Results from the childhood arthritis prospective study. Rheumatology (Oxford) 49(1):116\u2013122","DOI":"10.1093\/rheumatology\/kep352"},{"key":"1378_CR9","doi-asserted-by":"crossref","unstructured":"Iglesias E, Torrente-Segarra V, Bou R et al (2013) Non-systemic juvenile idiopathic arthritis outcome after reaching clinical remission with anti-TNF-\u03b1 therapy: a clinical practice observational study of patients who discontinued treatment. Rheumatol Int. doi:10.1007\/s00296-013-2884-z (Epub ahead of print)","DOI":"10.1007\/s00296-013-2884-z"},{"key":"1378_CR10","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/rheumatology\/ket248","volume":"52","author":"McErlane","year":"2013","unstructured":"McErlane F, Foster H, Davies R et al (2013) Biologic treatment response among adults with juvenile idiopathic arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology 52(10):1905\u20131913","journal-title":"Rheumatology"},{"key":"1378_CR11","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1136\/annrheumdis-2012-202031","volume":"72","author":"McErlane","year":"2013","unstructured":"McErlane F, Beresford MW, Baildam EM et al (2013) Childhood Arthritis Prospective Study (CAPS). Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis. Ann Rheum Dis 72(12):1983\u20131988","journal-title":"Ann Rheum Dis"},{"key":"1378_CR12","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1002\/art.10444","volume":"46","author":"Minden","year":"2002","unstructured":"Minden K, Niewerth M, Listing J et al (2002) Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum 46(9):2392\u20132401","journal-title":"Arthritis Rheum"},{"key":"1378_CR13","doi-asserted-by":"crossref","unstructured":"Minden K, Niewerth M, Zink A et al (2012) Long-term outcome of patients with JIA treated with etanercept, results of the biologic register JuMBO. Rheumatology (Oxford) 51(8):1407\u20131415","DOI":"10.1093\/rheumatology\/kes019"},{"key":"1378_CR14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00393-012-1063-z","volume":"72","author":"Minden","year":"2013","unstructured":"Minden K, Klotsche J, Niewerth M et al (2013) Biologikaregister JuMBO \u2013 Langzeitsicherheit von Biologikatherapie bei juveniler idiopathischer Arthritis. Z Rheumatol 72(4):339\u2013346","journal-title":"Z Rheumatol"},{"key":"1378_CR15","first-page":"265","volume":"Rheum","author":"Niewerth","year":"2011","unstructured":"Niewerth M, Minden K (2011) Transition \u2013 Der schwierige Weg des \u00dcbergangs von der p\u00e4diatrischen in die internistische Rheumatologie. Arthritis Rheum (Munch) 31(4):265\u2013269","journal-title":"Arthritis"},{"key":"1378_CR16","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1002\/art.30426","volume":"63","author":"Nordal","year":"2011","unstructured":"Nordal E, Zak M, Aalto K, Berntson L et al (2011) Nordic Study Group of Pediatric Rheumatology. Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis. Arthritis Rheum 63(9):2809\u20132818","journal-title":"Arthritis Rheum"},{"key":"1378_CR17","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/art.24539","volume":"61","author":"Oen","year":"2009","unstructured":"Oen K, Tucker L, Huber AM et al (2009) Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: results of a Canadian multicenter, prospective inception cohort study. Arthritis Rheum 61(8):1077\u20131086","journal-title":"Arthritis Rheum"},{"key":"1378_CR18","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.2337\/dc11-2163","volume":"35","author":"Rausch","year":"2012","unstructured":"Rausch JR, Hood KK, Delamater A et al (2012) Changes in treatment adherence and glycemic control during the transition to adolescence in type 1 diabetes. Diabetes Care 35(6):1219\u20131224","journal-title":"Diabetes Care"},{"key":"1378_CR19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fphar.2011.00060","volume":"2","author":"Ruperto","year":"2011","unstructured":"Ruperto N, Martini A (2011) Current medical treatments for juvenile idiopathic arthritis. Front Pharmacol 2(10):60","journal-title":"Front Pharmacol"},{"key":"1378_CR20","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1136\/ard.2010.143347","volume":"70","author":"Tynj\u00e4l\u00e4","year":"2011","unstructured":"Tynj\u00e4l\u00e4 P, V\u00e4h\u00e4salo P, Tarkiainen M et al (2011) Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial. Ann Rheum Dis 70(9):1605\u20131612","journal-title":"Ann Rheum Dis"},{"key":"1378_CR21","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1093\/rheumatology\/ket256","volume":"52","author":"Vidqvist","year":"2013","unstructured":"Vidqvist KL, Malin M, Varjolahti-Lehtinen T et al (2013) Disease activity of idiopathic juvenile arthritis continues through adolescence despite the use of biologic therapies. Rheumatology 52(11):1999\u20132003","journal-title":"Rheumatology"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-014-1378-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-014-1378-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-014-1378-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T16:36:18Z","timestamp":1559061378000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-014-1378-z"}},"subtitle":["\u00dcbergang von der p\u00e4diatrischen in die Erwachsenenversorgung","Transition from pediatric to adult care"],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["1378"],"URL":"https:\/\/doi.org\/10.1007\/s00393-014-1378-z","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}